---
document_datetime: 2023-09-21 17:41:50
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/imlygic-epar-all-authorised-presentations_en.pdf
document_name: imlygic-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3269206
conversion_datetime: 2025-12-28 04:24:14.918639
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## EU (MA) Number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

EU/1/15/1064/001 Imlygic 1x 10e6 PFU/ml Solution for injection Intralesional use Vial (Cycloolefinic polymer) 1 ml 1 x 10e6 PFU/ml EU/1/15/1064/002 Imlygic 1x 10e8 PFU/ml Solution for injection Intralesional use Vial (Cycloolefinic polymer) 1 ml 1 x 10e8 PFU/ml